Anette Siggervåg, Åse K Bekkelund, Jaakko Saraste, Henriette Aksnes
{"title":"通过高尔基体n端乙酰化了解脑钙化","authors":"Anette Siggervåg, Åse K Bekkelund, Jaakko Saraste, Henriette Aksnes","doi":"10.1093/brain/awaf175","DOIUrl":null,"url":null,"abstract":"Primary familial brain calcification (PFBC) provides valuable insights into the mechanisms underlying brain calcification as it singles out the proteins that potentially are involved in the relevant cellular pathways. To date, seven genes have been linked to PFBC, and studying their encoded proteins marks an exciting new era in understanding the disease mechanisms, which may ultimately lead to therapeutic strategies to prevent brain calcification. With each new gene found to be associated with PFBC due to pathogenic variants, an additional level of understanding is achieved. Here, we highlight the most recently discovered PFBC gene, encoding the Golgi-localized N-terminal acetyltransferase NAA60. We explore the novel perspectives gained from the understanding of this enzyme’s molecular, cellular and physiological properties. Interestingly, NAA60 shares a critical role with the most frequent PFBC gene, SLC20A2. Both these proteins seem to be involved in maintaining the structural integrity of the Golgi apparatus, as deficiency in either protein leads to Golgi fragmentation. Altered Golgi morphology is therefore emerging as a new significant topic in PFBC research, and we here discuss this topic in relation to existing knowledge regarding Golgi rearrangements and dysfunction as a factor in neurodegenerative diseases.","PeriodicalId":9063,"journal":{"name":"Brain","volume":"140 1","pages":""},"PeriodicalIF":10.6000,"publicationDate":"2025-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Understanding brain calcification via N-terminal acetylation at the Golgi apparatus\",\"authors\":\"Anette Siggervåg, Åse K Bekkelund, Jaakko Saraste, Henriette Aksnes\",\"doi\":\"10.1093/brain/awaf175\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Primary familial brain calcification (PFBC) provides valuable insights into the mechanisms underlying brain calcification as it singles out the proteins that potentially are involved in the relevant cellular pathways. To date, seven genes have been linked to PFBC, and studying their encoded proteins marks an exciting new era in understanding the disease mechanisms, which may ultimately lead to therapeutic strategies to prevent brain calcification. With each new gene found to be associated with PFBC due to pathogenic variants, an additional level of understanding is achieved. Here, we highlight the most recently discovered PFBC gene, encoding the Golgi-localized N-terminal acetyltransferase NAA60. We explore the novel perspectives gained from the understanding of this enzyme’s molecular, cellular and physiological properties. Interestingly, NAA60 shares a critical role with the most frequent PFBC gene, SLC20A2. Both these proteins seem to be involved in maintaining the structural integrity of the Golgi apparatus, as deficiency in either protein leads to Golgi fragmentation. Altered Golgi morphology is therefore emerging as a new significant topic in PFBC research, and we here discuss this topic in relation to existing knowledge regarding Golgi rearrangements and dysfunction as a factor in neurodegenerative diseases.\",\"PeriodicalId\":9063,\"journal\":{\"name\":\"Brain\",\"volume\":\"140 1\",\"pages\":\"\"},\"PeriodicalIF\":10.6000,\"publicationDate\":\"2025-05-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Brain\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/brain/awaf175\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/brain/awaf175","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Understanding brain calcification via N-terminal acetylation at the Golgi apparatus
Primary familial brain calcification (PFBC) provides valuable insights into the mechanisms underlying brain calcification as it singles out the proteins that potentially are involved in the relevant cellular pathways. To date, seven genes have been linked to PFBC, and studying their encoded proteins marks an exciting new era in understanding the disease mechanisms, which may ultimately lead to therapeutic strategies to prevent brain calcification. With each new gene found to be associated with PFBC due to pathogenic variants, an additional level of understanding is achieved. Here, we highlight the most recently discovered PFBC gene, encoding the Golgi-localized N-terminal acetyltransferase NAA60. We explore the novel perspectives gained from the understanding of this enzyme’s molecular, cellular and physiological properties. Interestingly, NAA60 shares a critical role with the most frequent PFBC gene, SLC20A2. Both these proteins seem to be involved in maintaining the structural integrity of the Golgi apparatus, as deficiency in either protein leads to Golgi fragmentation. Altered Golgi morphology is therefore emerging as a new significant topic in PFBC research, and we here discuss this topic in relation to existing knowledge regarding Golgi rearrangements and dysfunction as a factor in neurodegenerative diseases.
期刊介绍:
Brain, a journal focused on clinical neurology and translational neuroscience, has been publishing landmark papers since 1878. The journal aims to expand its scope by including studies that shed light on disease mechanisms and conducting innovative clinical trials for brain disorders. With a wide range of topics covered, the Editorial Board represents the international readership and diverse coverage of the journal. Accepted articles are promptly posted online, typically within a few weeks of acceptance. As of 2022, Brain holds an impressive impact factor of 14.5, according to the Journal Citation Reports.